Pancreatic cancer - Low survival rates;Bauchspeicheldrüsenkrebs - Heilungschancen minimal

Deutsches Arzteblatt

Volumn 105, Issue 14, 2008, Pages 255-262

  Beger, Hans G ^a,d   Rau, Bettina ^a,b   Gansauge, Frank ^a   Leder, Gerd ^c   Schwarz, Michael ^a   Poch, Bertram ^a  

^a Donauklinikum   (Austria)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Adjuvant chemotherapy; Early cancer dissemination into nerves; Lymph tissue and blood circulation; Pancreatic cancer; RO resection; Systemic disease

Indexed keywords

ALCOHOL; ALPHA INTERFERON; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ALCOHOL CONSUMPTION; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CIRCULATION; CLINICAL TRIAL; FOLLOW UP; GERMANY; HUMAN; INFORMATION RETRIEVAL; METASTASIS; PANCREAS CANCER; REVIEW; SMOKING; SURVIVAL RATE; SURVIVAL TIME;

EID: 42049089128     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0255     Document Type: Review

References (25)

1. Krebs in Deutschland, Krebsregister: 5. überarbeitete, aktualisierte Ausgabe. Saarbrücken: Robert Koch-Institut und GEKID 2006; 36-8.
2. Michand de Gonzalez A, Sweetland S, Spencer E: A meta-analysis of obesity and risk of pancreatic cancer. JAMA 2001; 286: 921-9.
3. Muscat J, Stellman S, Hoffmann D, Wynder EL: Smoking and pancreatic cancer in men and women. Cancer Epidemiology, Biomarkers and Prevention 1997; 6: 15-9.
4. Lowenfels AP et al.: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328: 1433-7.
5. Greenhalf W, Neoptolemos J: Familial pancreatic cancer. In: Beger HG et al. eds: The Pancreas. Oxford: Blackwell Publisher 2008 (in press).
6. Whitcomb D: Hereditary chronic pancreatitis. The Pancreas 2e, Eds. Beger HG, et al. Oxford: Blackwell Publisher, 2008 (in press).
7. Beger HG, Schlosser W, Friess HM, Büchler MW: Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience. Ann Surg 1999; 230: 512-9.
8. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C et al.: International consensus guidelines for mangement of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatol 2006; 6: 17-32.
9. Gudjonsson B: Survival statistics gone awry, pancreatic cancer, a case in point. J Clin Gastroenterol 2002; 35: 180-4.
10. Hermanek P: Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 1991; 17: 167-72.
11. Takahashi T, Ishikara H, Kato H et al.: Intra-pancreatic, extratumoral perineural invasion. Acta Pathol Jpn 1992; 42: 99-103.
12. Wittekind Ch, Meyer HJ, Baetz E (eds.): TNM-Klassifikation maligner Tumoren (International Union against Cancer-UICC) Berlin, Heidelberg, New York: Springer Verlag 2003; 86-8.
13. Inoue S, Nakao A, Kasai Y et al.: Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis. Jpn. J Cancer Res 1995; 86: 626-30.
14. Wolfrum F, Vogel I, Fändrich F, Kalthoff H: Detection and clinical implications of minimal residual disease in gastro-intestinal cancer. LAS 2005; 390: 430-41.
15. Okusaka T, Okada S, Ueno H et al.: Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings. Pancreas 2001; 22: 279-84.
16. Wintersperger BJ, Nikolaou K, Becker CR: Multidetector-row CT angiography of the aorta and visceral arteries. Semin Ultrasound CT MR 2004; 25: 25-40.
17. Richard KR, Semelka RC, Hyslop WB et al.: Suspected pancreatic cancer: evaluation by dynamic gadolinium enhanced 3-D-gradientecho-MRI. AJR Am J Roentgenol 2005; 185: 700-3.
18. Jimenez RE, Warshaw AL, Rattner DW, Willett CG, McGnath D, Fernandez-del Castillo C: Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg 2000; 135: 409-14.
19. Adler G, Seufferlein T, Bischoff SC et al.: S3-Leitlinien "Exokrines Pankreaskarziom" 2007. Ergebnis einer evidenzbasierten Konsensuskonferenz. Gastroenterologie 2007; 6: 487-523.
20. Oettle H, Post S, Neuhaus P, Gelldorf K et al.: Adjuvant chemotherapy with Genzitakine vs observation in patients undergoing curative-intent resection of pancreatic cancer. JAMA 2007; 297: 267-77.
21. Selvia R, Fernandez-del Castillo C, Bassi C, Thayer SP et al.: Main-duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2004; 239: 678-87.
22. Shoup M, Conlon K, Klimstra D, Brennan MF: Is extended resection for adenocarcinoma of the body and tail of the pancreas justified? J Gastrointest Surg 2003; 7: 946-52.
23. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R: Surgery for exocrine pancreatic cancer - who are the 5- and 10-year-survivors? Oncology 1995; 52: 353-9.
24. Beger HG, Rau B, Gansauge F, Poch B, Link KH: Treatment of pancreatic cancer: challenge of facts. World J Surg 2003; 27: 1075-84.
25. Neoptolemos JP, Stocken DD, Friess H et al.: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350; 1200-10.